These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 16581155)
1. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. Coia JE; Duckworth GJ; Edwards DI; Farrington M; Fry C; Humphreys H; Mallaghan C; Tucker DR; ; ; J Hosp Infect; 2006 May; 63 Suppl 1():S1-44. PubMed ID: 16581155 [TBL] [Abstract][Full Text] [Related]
2. Should healthcare workers be screened routinely for meticillin-resistant Staphylococcus aureus? Hill SF J Hosp Infect; 2011 Nov; 79(3):275. PubMed ID: 21767895 [No Abstract] [Full Text] [Related]
3. Staff-to-patient transmission of meticillin-resistant Staphylococcus aureus: do bacterial factors play a role? Haill C; Allwood A; Kearns AM; Jenks PJ J Hosp Infect; 2011 Nov; 79(3):275-7. PubMed ID: 21813207 [No Abstract] [Full Text] [Related]
4. Managing methicillin-resistant staphylococci: a paradigm for preventing nosocomial transmission of resistant organisms. Henderson DK Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S46-54: discussion S64-73. PubMed ID: 16813982 [TBL] [Abstract][Full Text] [Related]
5. National guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus--what do they tell us? Humphreys H Clin Microbiol Infect; 2007 Sep; 13(9):846-53. PubMed ID: 17608744 [TBL] [Abstract][Full Text] [Related]
6. MRSA patients: proven methods to treat colonization and infection. Boyce JM J Hosp Infect; 2001 Aug; 48 Suppl A():S9-14. PubMed ID: 11759035 [TBL] [Abstract][Full Text] [Related]
7. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). Appelbaum PC Int J Antimicrob Agents; 2007 Nov; 30(5):398-408. PubMed ID: 17888634 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effectiveness of common hospital hand disinfectants against methicillin-resistant Staphylococcus aureus, glycopeptide-intermediate S. aureus, and heterogeneous glycopeptide-intermediate S. aureus. Wootton M; Walsh TR; Davies EM; Howe RA Infect Control Hosp Epidemiol; 2009 Mar; 30(3):226-32. PubMed ID: 19199533 [TBL] [Abstract][Full Text] [Related]
9. Managing methicillin-resistant staphylococci: a paradigm for preventing nosocomial transmission of resistant organisms. Henderson DK Am J Med; 2006 Jun; 119(6 Suppl 1):S45-52; discussion S62-70. PubMed ID: 16735151 [TBL] [Abstract][Full Text] [Related]
10. Vancomycin intermediate and resistant Staphylococcus aureus. What the nephrologist needs to know. McDonald LC; Hageman JC Nephrol News Issues; 2004 Oct; 18(11):63-4, 66-7, 71-2 passim. PubMed ID: 15551615 [TBL] [Abstract][Full Text] [Related]
11. A bug's life. Winter G Nurs Stand; 2005 Apr 27-May 3; 19(33):16-8. PubMed ID: 15884297 [TBL] [Abstract][Full Text] [Related]
12. Staphylococcus aureus with reduced susceptibility to vancomycin in healthcare settings. Spagnolo AM; Orlando P; Panatto D; Amicizia D; Perdelli F; Cristina ML J Prev Med Hyg; 2014 Dec; 55(4):137-44. PubMed ID: 26137787 [TBL] [Abstract][Full Text] [Related]
13. Implementation of an industrial systems-engineering approach to reduce the incidence of methicillin-resistant Staphylococcus aureus infection. Muder RR; Cunningham C; McCray E; Squier C; Perreiah P; Jain R; Sinkowitz-Cochran RL; Jernigan JA Infect Control Hosp Epidemiol; 2008 Aug; 29(8):702-8, 7 p following 708. PubMed ID: 18624651 [TBL] [Abstract][Full Text] [Related]
14. A systematic review of the evidence for interventions for the prevention and control of meticillin-resistant Staphylococcus aureus (1996-2004): report to the Joint MRSA Working Party (Subgroup A). Loveday HP; Pellowe CM; Jones SR; Pratt RJ J Hosp Infect; 2006 May; 63 Suppl 1():S45-70. PubMed ID: 16616800 [TBL] [Abstract][Full Text] [Related]
15. The role of gowns in preventing nosocomial transmission of methicillin-resistant Staphylococcus aureus (MRSA): gown use in MRSA control. Grant J; Ramman-Haddad L; Dendukuri N; Libman MD Infect Control Hosp Epidemiol; 2006 Feb; 27(2):191-4. PubMed ID: 16465638 [TBL] [Abstract][Full Text] [Related]
16. [Nasal carriage of meticillin-resistant Staphylococcus aureus among health care personnel in Abidjan (Côte d'lvoire)]. Akoua Koffi C; Dje K; Toure R; Guessennd N; Acho B; Faye Kette H; Loukou YG; Dosso M Dakar Med; 2004; 49(1):70-4. PubMed ID: 15782482 [TBL] [Abstract][Full Text] [Related]
17. Control of methicillin-resistant Staphylococcus aureus in the hospital setting. Herwaldt LA Am J Med; 1999 May; 106(5A):11S-18S; discussion 48S-52S. PubMed ID: 10348059 [TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model. Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524 [TBL] [Abstract][Full Text] [Related]
19. Cultures, bundles, and other options for MRSA control. ECRI Insitute Healthc Hazard Manage Monit; 2007 Jul; 20(11):1-10. PubMed ID: 17619466 [No Abstract] [Full Text] [Related]
20. Experience applying the UK meticillin-resistant Staphylococcus aureus (MRSA) guidelines in a tertiary referral hospital in the United Arab Emirates 1999-2002: same guidelines, different cultures. Jumaa PA; Hateley PM; Bacon S; Salabsalo FL; Neringer R J Hosp Infect; 2007 Dec; 67(4):323-8. PubMed ID: 18023924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]